Business Wire

O-RAN ALLIANCE Welcomes Four New OTICs In North America

17.8.2023 18:19:00 EEST | Business Wire | Press release

Share

The O-RAN ALLIANCE, fulfilling its mission to transform Radio Access Networks to be open, intelligent, virtualized and fully interoperable, today announced that it has approved four new Open Testing and Integration Centres (OTIC) in North America. OTICs are vendor-independent, open, and qualified labs approved by the O-RAN ALLIANCE that issue awards in the O-RAN Certification and Badging Program, so that operators can deploy products at scale and with confidence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230817436719/en/

North American OTIC in the Boston Area (Northeastern University)

The OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University promotes research, development, and testing of next-generation intelligent Open Radio Access Networks (Open RAN). The OTIC within the Open6G hub is a resource for industry, academia, and government toward multi-vendor interoperability and validation of end-to-end control logic for programmable networks, including artificial intelligence (AI) and machine learning (ML) algorithms. The OTIC provides testing equipment and services to validate disaggregated base stations and RAN Intelligent Controllers (RICs), including custom applications (i.e., xApps and rApps). Applications can be tested against different RAN implementations (including commercial and open-source stacks), in emulated or over-the-air environments. The OTIC platforms include Colosseum, the world’s largest wireless network emulator with hardware-in-the-loop, already showcased as a digital twin for multiple Open RAN tests and trials.

“Northeastern’s Open6G is at the forefront of innovation in Open RAN testing, architectures, algorithms, software, and experimentation. Together with our partners, we are creating an innovation and testing ecosystem that will continue to serve government, industry, and academia,” says Tommaso Melodia, Director of Northeastern University’s Institute for the Wireless Internet of Things.

North American OTIC in Central Iowa (ARA)

North American OTIC in Central Iowa (ARA) is hosted by the Center for Wireless, Communities, and Innovation (WiCI) at Iowa State University (ISU). It uses the newly deployed NSF funded ARA rural wireless platform and provides services for testing and integrating O-RAN technologies using state of the art wireless equipment and with the addition of agricultural and rural setting and equipment. To facilitate experimentation, ARA-OTIC has deployed multi-modal, long-distance, and high-capacity wireless x-haul platforms ranging from free space optical to mmWave and microwave bands, as well as advanced wireless access platforms such as low-UHF massive MIMO systems, software-defined-radio (SDR) and programmable commercial-off-the-shelf (COTS) 5G systems, and open-source 5G-and-beyond software platforms to integrate modeling and simulation environments as well as management and decision systems. ARA-OITC is fully committed to promoting the openness of O-RAN in research and innovation by providing a unique platform.

“We believe ARA-OTIC offers a unique platform for testing O-RAN equipment and services that will bring wireless innovation to AgTech and other rural industries,” said Professor Hongwei Zhang, Director of North American OTIC in Central Iowa (ARA).

North American OTIC in Salt Lake City (POWDER)

North American OTIC in Salt Lake City (POWDER) supports end-to-end Open RAN testing in lab and field scenarios and has developed a Testing Orchestration and Testing Automation (TOTA) framework to provide streamlined, on-demand testing capabilities. OTIC services provided by POWDER include interoperability and end-to-end testing, badging and certification. The OTIC offers additional Open RAN related services including use case and proof-of-concept development and evaluation, functional testing in lab and field environments, and Open RAN intelligent ecosystem research, testing and development.

“We are very pleased with POWDER’s OTIC designation,” said Kobus Van der Merwe, Professor in the Kahlert School of Computing and Director of the POWDER platform and the North American OTIC in Salt Lake City (POWDER). “Being an OTIC will allow POWDER to provide 5G/6G and specifically Open RAN testing, development and certification services, and form the basis for continued collaborative research efforts with industry partners. POWDER’s automated testing and lab-as-a-service features and the fact that POWDER provides both indoor and outdoor facilities are unique capabilities in this domain.”

North American OTIC in Washington, DC/Arlington, VA

The Commonwealth Cyber Initiative (CCI) xG Testbed at Virginia Tech, in partnership with AT&T, DISH Network, and Verizon, emphasizes programmability and interoperability, relying when possible on open interfaces and open-source software. Key capabilities include securing 5G and next-generation mobile networks, AI assurance, multi-vendor interoperability, conformance and performance testing, and an end-to-end intelligent RAN control-loop supported by an AI/ML framework. CCI’s OTIC features indoor and outdoor testing environments, which can validate disaggregated RAN components — O-RAN Centralized Unit (O-CU), O-RAN Distributed Unit (O-DU), O-RAN Radio Unit (O-RU) — Over-The-Air (OTA) across locations and transport networks. Researchers can test RAN components’ interaction with Radio Intelligent Controllers (RICs) and microservices/applications that are AI/ML-based (i.e., xApps and rApps). Related services include use case and proof-of-concept development and evaluation.

“The Commonwealth Cyber Initiative is committed to securing the next generation of wireless network technologies,” said Aloizio P. DaSilva, CCI xG Testbed director, North American OTIC in Washington, DC/Arlington, VA. “By conducting interoperability, conformance and performance tests as an OTIC site, we will identify and address key gaps, spurring innovation and early adoption in the wireless marketplace.”

“The O-RAN ALLIANCE welcomes four additional OTICs to North America, bringing the worldwide total to 15,” said Alex Jinsung Choi, Chairman of the Board, O-RAN ALLIANCE. “The essential function of OTICs to certify and badge products complements the work of our operator members and contributing vendors to continuously develop products and operationalize O-RAN specifications.”

About O-RAN ALLIANCE

The O-RAN ALLIANCE is a world-wide community of more than 300 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the RAN industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information, please visit www.o-ran.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

O-RAN ALLIANCE PR
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release

VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye